Treatment Snapshot

Suitable for:

Post menopausal women suffering from dryness, pain or vaginal atrophy

Time for Treatment:

30 minutes


No downtime


Solution for symptoms of vaginal atrophy using photo-thermal treatment of the vaginal canal which restores function of vaginal mucosa. Safe treatment without long-term hormonal therapy which is minimally invasive with no downtime.

Treatments Required:

3 treatments, 1 month apart

Treatment Pricing

  • RenovaLase:


    per treatment

The Detail

What is RenovaLase® ?

RenovaLase® is an innovative and unique, non-invasive 2940 nm Er:YAG laser therapy for the symptoms of vaginal atrophy. It is based on non-ablative photothermal treatment of the vaginal canal. Clinical studies show that it is an efficient, easy-to-use, quick and safe procedure, eliminating the need for long-term estrogen administration.


Promising clinical Results

The latest scientific results presented by Dr. Marco Gambacciani1 and Dr. Adrian Gaspar2-4 clearly show a noticeable improvement in the symptoms of vaginal atrophy. Results show favourable changes in the tropism of the vaginal mucosa, with increases in collagen and vascularization as well as in the glycogen level and the epithelial thickness. There was no ablation of the tissue or thermal damage and no adverse events. The positive effects were long lasting as results were sustained at follow-up 6 months after the treatment. With no need for long-term estrogen treatment, RenovaLase® is also appropriate for patients with estrogen-dependent cancer (such as endometrial cancer, breast cancer, etc.) or with a family background of such cancers, as shown in clinical studies by Dr. Bojanini5 and Dr. Gambacciani2 .

How does RenovaLase® work?

The RenovaLase® treatment is based on laser-induced controlled mild heating of the vaginal tissue, which stimulates angiogenesis, fibroblast activity and new collagen formation, without thermal or ablative damage. The final result is increased epithelial thickness as well as vascularization of the lamina propria, along with a reduction of symptoms such as dryness, itching, irritation and dyspareunia.